Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study
Publication date: Available online 13 December 2018Source: Actas Urológicas Españolas (English Edition)Author(s): A. Alcántara Montero
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Source Type: research
More News: Overactive Bladder | Overactive Bladder Syndrome | Study | Urology & Nephrology | VESIcare